Trials / Active Not Recruiting
Active Not RecruitingNCT06566729
MRD in High-risk EBC
Application of Molecular Residual Disease in the Recurrence Monitoring and Response Predicting of High-risk Early Breast Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 125 (estimated)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, prospective, observational cohort study, 125 patients with early-stage high-risk breast cancer will be enrolled, perioperative surgical specimens, peripheral blood specimens before and after adjuvant therapy and follow-up will be collected, and the predictive effect of MRD of molecular residual lesions on recurrence events and drug efficacy will be evaluated through dynamic monitoring, so as to further accurately stratify the risk and guide clinical intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Peripheral blood sample collection | In this study, peripheral blood samples would be collected before adjuvant chemotherapy, after adjuvant chemotherapy and every 3 months thereafter until 2 years after surgery. |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2024-09-30
- Completion
- 2028-04-01
- First posted
- 2024-08-22
- Last updated
- 2024-08-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06566729. Inclusion in this directory is not an endorsement.